Clinical Trial Update: The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ultrasound-guided botulinum toxin injections for post-stroke upper extremity spasticity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Disorders
• Spasticity

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Sisli Hamidiye Etfal Training and Research Hospital | Conditions: Cerebrovascular Disorders, Spasticity, Muscle | Phase 4 | Status: WITHDRAWN